feed,title,long_url,short_url
BioRxiv,Clinical grade ACE2 as a universal agent to block SARS-CoV-2 variants,https://biorxiv.org/cgi/content/short/2021.09.10.459744v1?rss=1,https://j.mp/3C1HrSx
BioRxiv,Pharmacological perturbation of intracellular dynamics as a SARS-CoV-2 antiviral strategy,https://biorxiv.org/cgi/content/short/2021.09.10.459410v1?rss=1,https://j.mp/3E7xPY5
BioRxiv,Intranasal administration of a VLP-based vaccine against COVID-19 induces neutralizing antibodies against SARS-CoV-2 and Variants of Concerns,https://biorxiv.org/cgi/content/short/2021.09.10.459749v1?rss=1,https://j.mp/3A2dJfu
